Cargando…

NSD2 Promotes Renal Cancer Progression Through Stimulating Akt/Erk Signaling

BACKGROUND: Nuclear receptor suppressor of variegation, enhancer of zeste, and trithorax (SET) domain-containing 2 (NSD2), is a well-known histone lysine methyltransferase (HMTase). The aim of this study was to investigate the biological role of NSD2 in clear cell renal cell carcinoma (ccRCC). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xu, Piao, Lianhua, Xu, Xiaoshuang, Luo, Fengbao, Liu, Zhiwei, He, Xiaozhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974414/ https://www.ncbi.nlm.nih.gov/pubmed/32021450 http://dx.doi.org/10.2147/CMAR.S222673

Ejemplares similares

Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition
por: Han, Xu, et al.
Publicado: (2019)

The role of histone lysine methyltransferase NSD3 in cancer
por: Han, Xu, et al.
Publicado: (2018)

Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis
por: Liu, Zhiwei, et al.
Publicado: (2017)

ERK and p38 Upregulation versus Bcl-6 Downregulation in Rat Kidney Epithelial Cells Exposed to Prolonged Hypoxia
por: Luo, Fengbao, et al.
Publicado: (2017)

Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection
por: Shi, Jian, et al.
Publicado: (2015)

In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L
por: Morishita, Masayo, et al.
Publicado: (2014)

Erythrocyte membrane protein band 4.1-like 3 inhibits osteosarcoma cell invasion through regulation of Snai1-induced epithelial-to-mesenchymal transition
por: Yuan, Xiaofeng, et al.
Publicado: (2020)

Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis
por: Gameiro, Steven F., et al.
Publicado: (2021)

NSD2 is a conserved driver of metastatic prostate cancer progression
por: Aytes, Alvaro, et al.
Publicado: (2018)

NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis
por: Peri, Suraj, et al.
Publicado: (2017)

CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway
por: Zhang, Shuhua, et al.
Publicado: (2019)

NSD1 in erythroid differentiation and leukemogenesis
por: Tauchmann, Samantha, et al.
Publicado: (2020)

Overexpression of Nrf2 promotes colon cancer progression via ERK and AKT signaling pathways
por: Lee, Yoon Jin, et al.
Publicado: (2020)

Daam1 Overexpression Promotes Gastric Cancer Progression and Regulates ERK and AKT Signaling Pathways
por: Zhang, Yue, et al.
Publicado: (2021)

Loss of histone H4 lysine 20 trimethylation in osteosarcoma is associated with aberrant expression ofhistone methyltransferase SUV420H2
por: Piao, Lianhua, et al.
Publicado: (2020)

STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways
por: Chen, Bing, et al.
Publicado: (2016)

NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2
por: Zhou, Xue‐liang, et al.
Publicado: (2018)

The δ-Opioid Receptor Differentially Regulates MAPKs and Anti-inflammatory Cytokines in Rat Kidney Epithelial Cells Under Hypoxia
por: Luo, Fengbao, et al.
Publicado: (2020)

Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses
por: Xu, Duo, et al.
Publicado: (2022)

Proteosomal degradation of NSD2 by BRCA1 promotes leukemia cell differentiation
por: Park, Jin Woo, et al.
Publicado: (2020)

DEAD-box Helicase 27 Promotes Hepatocellular Carcinoma Progression Through ERK Signaling
por: Xiaoqian, Wang, et al.
Publicado: (2021)

NSD3S stabilizes MYC through hindering its interaction with FBXW7
por: Gonzalez-Pecchi, Valentina, et al.
Publicado: (2019)

The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3
por: Wang, Chunmei, et al.
Publicado: (2017)

NSD3 keeps IRF3 active
por: Mino, Takashi, et al.
Publicado: (2017)

Covalent inhibition of NSD1 histone methyltransferase
por: Huang, Huang, et al.
Publicado: (2020)

Pivotal roles of protein 4.1B/DAL-1, a FERM-domain containing protein, in tumor progression (Review)
por: Yuan, Xiaofeng, et al.
Publicado: (2019)

CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation
por: Zhang, Shuhua, et al.
Publicado: (2022)

The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the Substrate
por: Li, Yan, et al.
Publicado: (2009)

FLOT1 promotes gastric cancer progression and metastasis through BCAR1/ERK signaling
por: Wang, Ran, et al.
Publicado: (2023)

Anlotinib Alleviates Renal Fibrosis via Inhibition of the ERK and AKT Signaling Pathways
por: Sun, Donglin, et al.
Publicado: (2023)

Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling
por: Tsai, M-C, et al.
Publicado: (2015)

Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway
por: Indramanee, Somsiri, et al.
Publicado: (2019)

PHF14 Promotes Cell Proliferation and Migration through the AKT and ERK1/2 Pathways in Gastric Cancer Cells
por: Zhao, Yuzu, et al.
Publicado: (2020)

ERK and Akt exhibit distinct signaling responses following stimulation by pro-angiogenic factors
por: Song, Min, et al.
Publicado: (2020)

Promotion of Keratinocyte Proliferation by Tracheloside through ERK1/2 Stimulation
por: Kim, JaeGoo, et al.
Publicado: (2018)

NSD2 as a Promising Target in Hematological Disorders
por: Azagra, Alba, et al.
Publicado: (2022)

SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling
por: Xu, Ming, et al.
Publicado: (2020)

Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling
por: Yang, Zhen, et al.
Publicado: (2022)

SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling
por: Bao, Fan, et al.
Publicado: (2023)

Tspan9 Induces EMT and Promotes Osteosarcoma Metastasis via Activating FAK-Ras-ERK1/2 Pathway
por: Shao, Shijie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c32eopl4uucdiqqkdh2ti21t4u